Literature DB >> 11583573

Promoter I of the ovine acetyl-CoA carboxylase-alpha gene: an E-box motif at -114 in the proximal promoter binds upstream stimulatory factor (USF)-1 and USF-2 and acts as an insulin-response sequence in differentiating adipocytes.

M T Travers1, A J Vallance, H T Gourlay, C A Gill, I Klein, C B Bottema, M C Barber.   

Abstract

Acetyl-CoA carboxylase-alpha (ACC-alpha) plays a central role in co-ordinating de novo fatty acid synthesis in animal tissues. We have characterized the regulatory region of the ovine ACC-alpha gene. Three promoters, PI, PII and PIII, are dispersed throughout 50 kb of genomic DNA. Expression from PI is limited to adipose tissue and liver. Sequence comparison of the proximal promoters of ovine and mouse PIs demonstrates high nucleotide identity and that they are characterized by a TATA box at -29, C/EBP (CCAAT enhancer-binding protein)-binding motifs and multiple E-box motifs. A 4.3 kb ovine PI-luciferase reporter construct is insulin-responsive when transfected into differentiated ovine adipocytes, whereas when this construct is transfected into ovine preadipocytes and HepG2 cells the construct is inactive and is not inducible by insulin. By contrast, transfection of a construct corresponding to 132 bp of the proximal promoter linked to a luciferase reporter is active and inducible by insulin in all three cell systems. Insulin signalling to the -132 bp construct in differentiated ovine adipocytes involves, in part, an E-box motif at -114. Upstream stimulatory factor (USF)-1 and USF-2, but not sterol regulatory element-binding protein 1 (SREBP-1), are major components of protein complexes that bind this E-box motif. Activation of the 4.3 kb PI construct in differentiated ovine adipocytes is associated with endogenous expression of PI transcripts throughout differentiation; PI transcripts are not detectable by RNase-protection assay in ovine preadipocytes, HepG2 cells or 3T3-F442A adipocytes. These data indicate the presence of repressor motifs in PI that are required to be de-repressed during adipocyte differentiation to allow induction of the promoter by insulin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583573      PMCID: PMC1222145          DOI: 10.1042/0264-6021:3590273

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  Repression of the acetyl-CoA carboxylase gene in ovine adipose tissue during lactation: the role of insulin responsiveness.

Authors:  M T Travers; R G Vernon; M C Barber
Journal:  J Mol Endocrinol       Date:  1997-10       Impact factor: 5.098

2.  Cloning of human acetyl-CoA carboxylase-beta and its unique features.

Authors:  J Ha; J K Lee; K S Kim; L A Witters; K H Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

3.  Identification of a second human acetyl-CoA carboxylase gene.

Authors:  J Widmer; K S Fassihi; S C Schlichter; K S Wheeler; B E Crute; N King; N Nutile-McMenemy; W W Noll; S Daniel; J Ha; K H Kim; L A Witters
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

4.  Human acetyl-CoA carboxylase 2. Molecular cloning, characterization, chromosomal mapping, and evidence for two isoforms.

Authors:  L Abu-Elheiga; D B Almarza-Ortega; A Baldini; S J Wakil
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

5.  Promoter usage determines tissue specific responsiveness of the rat acetyl-CoA carboxylase gene.

Authors:  T S Kim; P Leahy; H C Freake
Journal:  Biochem Biophys Res Commun       Date:  1996-08-14       Impact factor: 3.575

6.  Glucose-dependent liver gene expression in upstream stimulatory factor 2 -/- mice.

Authors:  V S Vallet; A A Henrion; D Bucchini; M Casado; M Raymondjean; A Kahn; S Vaulont
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

7.  Upstream stimulatory factor binding to the E-box at -65 is required for insulin regulation of the fatty acid synthase promoter.

Authors:  D Wang; H S Sul
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

8.  Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1.

Authors:  J B Kim; P Sarraf; M Wright; K M Yao; E Mueller; G Solanes; B B Lowell; B M Spiegelman
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

9.  Two CACGTG motifs with proper spacing dictate the carbohydrate regulation of hepatic gene transcription.

Authors:  H M Shih; Z Liu; H C Towle
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

10.  Upstream stimulatory factors bind to insulin response sequence of the fatty acid synthase promoter. USF1 is regulated.

Authors:  D Wang; H S Sul
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

View more
  14 in total

1.  Functional development of the mammary gland: use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution.

Authors:  Michael C Rudolph; James L McManaman; Larry Hunter; Tzulip Phang; Margaret C Neville
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

2.  Upstream transcription factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene-gene interactions.

Authors:  Konstantinos Kantartzis; Andreas Fritsche; Fausto Machicao; Michael Stumvoll; Jürgen Machann; Fritz Schick; Hans-Ulrich Häring; Norbert Stefan
Journal:  J Mol Med (Berl)       Date:  2006-09-26       Impact factor: 4.599

3.  Comparative Approach of the de novo Fatty Acid Synthesis (Lipogenesis) between Ruminant and Non Ruminant Mammalian Species: From Biochemical Level to the Main Regulatory Lipogenic Genes.

Authors:  G P Laliotis; I Bizelis; E Rogdakis
Journal:  Curr Genomics       Date:  2010-05       Impact factor: 2.236

4.  Induction of transcripts derived from promoter III of the acetyl-CoA carboxylase-alpha gene in mammary gland is associated with recruitment of SREBP-1 to a region of the proximal promoter defined by a DNase I hypersensitive site.

Authors:  Michael C Barber; Amanda J Vallance; Helen T Kennedy; Maureen T Travers
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

5.  Human acetyl-CoA carboxylase 1 gene: presence of three promoters and heterogeneity at the 5'-untranslated mRNA region.

Authors:  Jianqiang Mao; Subrahmanyam S Chirala; Salih J Wakil
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

6.  Interaction of C/EBP-beta and NF-Y factors constrains activity levels of the nutritionally controlled promoter IA expressing the acetyl-CoA carboxylase-alpha gene in cattle.

Authors:  Xuanming Shi; Cornelia C Metges; Hans-Martin Seyfert
Journal:  BMC Mol Biol       Date:  2012-06-27       Impact factor: 2.946

7.  Genetic variation of glucose transporter-1 (GLUT1) and albuminuria in 10,278 European Americans and African Americans: a case-control study in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Charles C Hsu; Wenhong L Kao; Michael W Steffes; Tejal Gambir; Frederick L Brancati; Charles W Heilig; Alan R Shuldiner; Eric A Boerwinkle; Josef Coresh
Journal:  BMC Med Genet       Date:  2011-01-19       Impact factor: 2.103

Review 8.  Key stages in mammary gland development. Secretory activation in the mammary gland: it's not just about milk protein synthesis!

Authors:  Steven M Anderson; Michael C Rudolph; James L McManaman; Margaret C Neville
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

9.  Body mass index is associated with USF1 haplotype in Korean premenopausal women.

Authors:  Seong-Kyu Lee; Hyun-Jin Kim; Byung-Joon Kim; Young-Suk Jo; Kang-Seo Park; Haing-Woon Baik; Sung Hee Hyun; Je Chul Lee; Soon Ae Kim
Journal:  J Korean Med Sci       Date:  2008-02       Impact factor: 2.153

10.  USF2 inhibits C/EBP-mediated transcriptional regulation of the RIIbeta subunit of cAMP-dependent protein kinase.

Authors:  Maria Krudtaa Dahle; Kjetil Taskén; Kristin Austlid Taskén
Journal:  BMC Mol Biol       Date:  2002-06-21       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.